Aphex BioCleanse Systems, Inc. announced that its Board of Directors has appointed Anthony Fedor, current Chairman of the Board, as the Company's Interim Chief Executive Officer effective August 23, 2021. Fedor will continue to perform his duties as Chairman of the Board while holding the title of Interim President and CEO. Aphex has launched a CEO search process to identify appropriate candidates for which it expects to complete in the coming months as the Company looks to bring in new leadership. The new leadership direction will allow the Company to bring in an executive with more experience scaling similar organizations.